FINE FOODS & PHARMACEUTICALS (FF.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:FF - IT0005215329 - Common Stock
FF.MI Key Statistics, Chart & Performance
The current stock price of FF.MI is 9.56 EUR. In the past month the price increased by 0.21%. In the past year, price increased by 15.18%.
FF.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DIM.PA | SARTORIUS STEDIM BIOTECH | 48.72 | 20.44B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 48.54 | 20.36B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 54.3 | 18.54B | ||
| SRT.DE | SARTORIUS AG | 41.89 | 14.30B | ||
| QIA.DE | QIAGEN N.V. | 19.24 | 8.43B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 15.57 | 2.27B | ||
| EVT.DE | EVOTEC SE | N/A | 1.94B | ||
| GXI.DE | GERRESHEIMER AG | 7.47 | 952.61M |
Related stock screener links
About FF.MI
Company Profile
Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
Company Info
FINE FOODS & PHARMACEUTICALS
Via Berlino, 39, Zingonia
Verdellino BERGAMO IT
Employees: 779
Phone: 390354821382
FINE FOODS & PHARMACEUTICALS / FF.MI FAQ
What does FF do?
Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
Can you provide the latest stock price for FINE FOODS & PHARMACEUTICALS?
The current stock price of FF.MI is 9.56 EUR. The price increased by 0.63% in the last trading session.
What is the dividend status of FINE FOODS & PHARMACEUTICALS?
FINE FOODS & PHARMACEUTICALS (FF.MI) has a dividend yield of 1.48%. The yearly dividend amount is currently 0.12.
What is the ChartMill technical and fundamental rating of FF stock?
FF.MI has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the analyst forecast for FF.MI stock?
11 analysts have analysed FF.MI and the average price target is 12.51 EUR. This implies a price increase of 30.88% is expected in the next year compared to the current price of 9.56.
Can you provide the growth outlook for FINE FOODS & PHARMACEUTICALS?
The Revenue of FINE FOODS & PHARMACEUTICALS (FF.MI) is expected to grow by 5.61% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
FF.MI Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to FF.MI. When comparing the yearly performance of all stocks, FF.MI turns out to be only a medium performer in the overall market: it outperformed 63.59% of all stocks.
FF.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to FF.MI. FF.MI has an average financial health and profitability rating.
FF.MI Financial Highlights
Over the last trailing twelve months FF.MI reported a non-GAAP Earnings per Share(EPS) of 0.89. The EPS increased by 147.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.07% | ||
| ROA | 6.89% | ||
| ROE | 13.58% | ||
| Debt/Equity | 0.44 |
FF.MI Forecast & Estimates
11 analysts have analysed FF.MI and the average price target is 12.51 EUR. This implies a price increase of 30.88% is expected in the next year compared to the current price of 9.56.
For the next year, analysts expect an EPS growth of 53.89% and a revenue growth 5.61% for FF.MI